STSteven Tracy

Steven Tracy

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Steven Tracy has a total of 50 co-authors. Here are the top co-authors by number of shared publications:

  • Nora M. Chapman

    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska, USA

    7 shared publications
  • K. M. Drescher

    Department of Medical Microbiology and Immunology, Creighton University School of Medicine, 2500 California Plaza, Omaha NE 68178, USA

    4 shared publications
  • Kristen M. Drescher

    Department of Medical Microbiology and Immunology, School of Medicine, Creighton University, Omaha, NE, USA

    4 shared publications
  • Jose R. Romero

    Department of Pediatrics, University of Nebraska Medical Center, Omaha, Nebraska

    3 shared publications
  • K. Kono

    Department of Pathology and Microbiology, University of Nebraska Medical Center, 986495 Nebraska Medical Center, Omaha NE 68198‐6495, USA

    3 shared publications
  • J. S. Leser

    Enterovirus Research Laboratory,1 Department of Pathology and Microbiology,3 Department of Pediatrics, University of Nebraska Medical Center, Omaha, Nebraska 68198,4 Department of Medical Microbiology and Immunology, Creighton University School of Medicine, Omaha, Nebraska 681782

    2 shared publications

Latest Publications

  • Open Access

    The Role of Creatine in the Development and Activation of Immune Responses

    by Eric C. Bredahl, Joan M. Eckerson, Steven M. Tracy, Thomas L. McDonald, Kristen M. Drescher

    The use of dietary supplements has become increasingly common over the past 20 years. Whereas supplements were formerly used mainly by elite athletes, age and fitness status no longer dictates who uses these substances. Indeed, many nutritional supplements are recommended by health care professionals to their patients. Creatine (CR) is a widely used dietary supplement that has been well-studied for its effects on performance and health. CR also aids in recovery from strenuous bouts of exercise by reducing inflammation. Although CR is considered to be very safe in recommended doses, a caveat is that a preponderance of the studies have focused upon young athletic individuals; thus there is limited knowledge regarding the effects of CR on children or the elderly. In this review, we examine the potential of CR to impact the host outside of the musculoskeletal system, specifically, the immune system, and discuss the available data demonstrating that CR can impact both innate and adaptive immune responses, together with how the effects on the immune system might be exploited to enhance human health.


  • Enteroviruses, hygiene and type 1 diabetes: toward a preventive vaccine

    by Kristen M. Drescher, Matthias von Herrath, Steven Tracy

    SUMMARY Enteroviruses and humans have long co‐existed. Although recognized in ancient times, poliomyelitis and type 1 diabetes (T1D) were exceptionally rare and not epidemic, due in large part to poor sanitation and personal hygiene which resulted in repeated exposure to fecal–oral transmitted viruses and other infectious agents and viruses and the generation of a broad protective immunity. As a function of a growing acceptance of the benefits of hygienic practices and microbiologically clean(er) water supplies, the likelihood of exposure to diverse infectious agents and viruses declined. The effort to vaccinate against poliomyelitis demonstrated that enteroviral diseases are preventable by vaccination and led to understanding how to successfully attenuate enteroviruses. Type 1 diabetes onset has been convincingly linked to infection by numerous enteroviruses including the group B coxsackieviruses (CVB), while studies of CVB infections in NOD mice have demonstrated not only a clear link between disease onset but an ability to reduce the incidence of T1D as well: CVB infections can suppress naturally occurring autoimmune T1D. We propose here that if we can harness and develop the capacity to use attenuated enteroviral strains to induce regulatory T cell populations in the host through vaccination, then a vaccine could be considered that should function to protect against both autoimmune as well as virus‐triggered T1D. Such a vaccine would not only specifically protect from certain enterovirus types but more importantly, also reset the organism's regulatory rheostat making the further development of pathogenic autoimmunity less likely. Copyright © 2014 John Wiley & Sons, Ltd.


  • Coxsackievirus can persist in murine pancreas by deletion of 5′ terminal genomic sequences

    by Steven Tracy, Shane Smithee, Abdulaziz Alhazmi, Nora Chapman

    Enterovirus infections are generally acute and rapidly cleared by the host immune response. Enteroviruses can at times persist in immunologically intact individuals after the rise of the type‐specific neutralizing immune response. The mechanism of enterovirus persistence was shown in group B coxsackieviruses (CVB) to be due to naturally‐occurring deletions at the 5′ terminus of the genome which variably impact the stem‐loop secondary structure called domain I. These deletions result in much slower viral replication and a loss of measurable cytopathic effect when such 5′ terminally deleted (TD) viruses are assayed in cell culture. The existence and persistence of CVB‐TD long after the acute phase of infection has been documented in hearts of experimentally inoculated mice and naturally infected humans but to date, the existence of TD enteroviral populations have not been documented in any other organ. Enteroviral infections have been shown to impact type 1 diabetes (T1D) onset in humans as well as in the non‐obese diabetic mouse model of T1D. The first step to studying the potential impact of CVB‐TD on T1D etiology is to determine whether CVB‐TD populations can arise in the pancreas. After inoculation of NOD diabetic mice with CVB, viral RNA persists in the absence of cytopathic virus in pancreas weeks past the acute infectious period. Analysis of viral genomic 5′ termini by RT‐PCR showed CVB‐TD populations displace the parental population during persistent replication in murine pancreata. J. Med. Virol. 87:240–247, 2015.


  • Open Access

    The microbiology of human hygiene and its impact on type 1 diabetes

    by Nora M. Chapman, Ken Coppieters, Matthias von Herrath, Steven Tracy

    The incidence of type 1 diabetes (T1D), as with several other autoimmune diseases and conditions, began to notably rise in the latter half of the last century. Most cases of T1D are not solely attributable to genetics and therefore, environmental influences are proposed to account for the difference. Humans live today in general under much more hygienic conditions than their ancestors. Although human enteroviruses (HEV) have been strongly implicated as causative environmental agents of T1D, recent work has shown that the bacterial genera in the gut of diabetics compared with non-diabetics, can vary significantly. Here, we consider these data in light of our non-hygienic human past in order to discuss a possible relationship between the resident bacterial biome and acute infectious events by HEV, suggesting how this may have influenced T1D incidences in the past and the risk for developing T1D today.


  • Enteroviruses and type 1 diabetes

    by Steven Tracy, Kristen M. Drescher, Nora M. Chapman

    Background: Human enteroviruses, which are transmitted via a faecal‐oral route, have long been associated with type 1 diabetes onset. Increased hygiene in the 20th century may now be responsible for a decreased chance of enterovirus exposure from an early age onward. Infections with enteroviruses may also be more likely to occur at a later age; the recurrent poliomyelitis epidemics in the 20th century were linked to increased hygiene, consistent with this hypothesis. The association of fewer enterovirus exposures and increased diabetes rates may seem at first non‐intuitive but may be explained using a combination of human observations and data from experimental coxsackie B virus infections in nonobese diabetic mice.Methods: Network for Pancreatic Organ Donors with Diabetes samples were examined for the presence of detectable enteroviral RNA by RT‐PCR.Results: Viral RNA was not detected.Conclusions: A role for enteroviruses in the aetiology of human type 1 diabetes is hard to refute but in order to definitively link enteroviruses in general, and specific viruses in particular, with the disease, pancreas biopsy tissue must become available at the time of disease diagnosis. Copyright © 2011 John Wiley & Sons, Ltd.


  • Enteroviruses, type 1 diabetes and hygiene: a complex relationship

    by S. Tracy, K. M. Drescher, J. D. Jackson, K. Kim, K. Kono

    Type 1 diabetes (T1D) is an autoimmune disease in which the immune system mounts an attack on the host's insulin‐producing β cells. Because most cases of T1D cannot be attributed only to individual genetics, it is strongly inferred that there is a significant environmental contribution, such as infection, impacting disease development. The human enteroviruses (HEV) are common picornaviruses often implicated as triggers of human T1D, although precisely which of the numerous HEV may be involved in human T1D development is unknown. Experiments using non‐obese diabetic (NOD) mice, commonly used to model T1D, show that induction of T1D by HEV infection in NOD mice is a multifactorial process involving both the virus and the host. Interestingly, results demonstrate that HEV infection of NOD mice can also induce long‐term protection from T1D under certain conditions, suggesting that a similar mechanism may occur in humans. Based upon both experimental animal and observational human studies, we postulate that HEV have a dual role in T1D development and can either cause or prevent autoimmune disease. Whichever outcome occurs depends upon multiple variables in the host‐virus equation, many of which can be deduced from results obtained from NOD mouse studies. We propose that the background to the sharply rising T1D incidences observed in the 20th century correlates with increased levels of hygiene in human societies. Viewing T1D in this perspective suggests that potential preventative options could be developed. Copyright © 2009 John Wiley & Sons, Ltd.


    • 1 January 2008
      • Vol. 323

    Group B coxsackieviruses. Preface.

    by Steven Oberste, Kristen Drescher, Steven Tracy


  • Group B Coxsackievirus Virulence

    by Steven Tracy, C. Gauntt

    That which is understood of virulence phenotypes in the picornaviruses derives in large part from studies of artificially attenuating phenotypes rather than through examination of naturally occurring virus strains. The CVB replicate well in a variety of different murine and human cell cultures, making them excellent viruses with which to engage the problem of how the host environment interacts with specific viral genetics to promote varying efficiencies of viral replication. It is not known how highly virulent CVB strains may arise but evidence suggests such strains are not the norm.


  • The CVB and Etiology of Type 1 Diabetes

    by Kristen M. Drescher, Steven Tracy

    The origins of type 1 diabetes (T1D) are largely unknown. Fewer than 50% of the cases of the disease are attributable to host genetics, indicating that environmental factors are involved in disease development. The most often cited environmental agents implicated as initiators of T1D are the human enteroviruses, in particular the group B coxsackieviruses (CVB). Although the connection between the CVB and T1D has not been firmly established, significant evidence supports the role of these pathogens in T1D development.


  • Coxsackievirus Infections and NOD Mice

    by Steven Tracy, Kristen M. Drescher

    Human enteroviruses (HEVs) like the group B coxsackieviruses (CVBs) are prime candidates for infectious, environmental causes of human type 1 diabetes (T1D). Non‐obese diabetic (NOD) female mice are well protected from T1D onset if inoculated with CVB when young. Older, prediabetic NOD mice can rapidly develop T1D following inoculation with CVB, mimicking clinical reports of disease‐associated T1D onset. The ability to induce rapid T1D in NOD mice is linked to the rate of replication of the CVB strain in β cell cultures and pancreatic tissue, indicating that any CVB strain is potentially diabetogenic under the correct conditions. Rapid T1D onset is preceded by CVB replication in islet cells including β cells. Although CVB strains do not productively infect healthy islets of young mice, CVBs can replicate in healthy islets in the presence of murine IL‐4. These models expand much of what is known or suspected regarding the etiologic role of HEVs in human T1D.